Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 5
Submit an article Journal homepage
197
Views
9
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

MPL W515L mutation in Chinese patients with myeloproliferative diseases

Wei Xu Department of Hematology, First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China
,
Jian-Yong Li Department of Hematology, First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, ChinaCorrespondence[email protected]
,
Jun Xia Department of Hematology, First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China
,
Su-Jiang Zhang Department of Hematology, First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China
,
Lei Fan Department of Hematology, First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China
&
Chun Qiao Department of Hematology, First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China
Pages 955-958 | Received 14 Jan 2008, Accepted 06 Mar 2008, Published online: 01 Jul 2009

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

K. F. Wong, W. S. Wong, Lisa L. P. Siu & T. C. Lau. (2009) JAK2 V617F mutation in myeloid neoplasms with 3q21 and 3q26 abnormalities in Chinese patients. Leukemia & Lymphoma 50:8, pages 1386-1388.
Read now

Articles from other publishers (8)

Bestoon Muhammad Saeed, Hisham Arif Getta, Najmaddin Khoshnaw, Goran Abdulqader, Aveen M. Raouf Abdulqader & Ali Ibrahim Mohammed. (2021) Prevalence of JAK2 V617F, CALR , and MPL W515L Gene Mutations in Patients with Essential Thrombocythemia in Kurdistan Region of Iraq . The Korean Journal of Clinical Laboratory Science 53:1, pages 41-48.
Crossref
Sohaila Eldeweny, Hosny Ibrahim, Ghada Elsayed & Mohamed Samra. (2019) MPL W515 L/K mutations in myeloproliferative neoplasms. Egyptian Journal of Medical Human Genetics 20:1.
Crossref
Mónica Mejía-Ochoa, Paola Andrea Acevedo Toro & Jaiberth Antonio Cardona-Arias. (2019) Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018. BMC Cancer 19:1.
Crossref
Chao Sun, Xin Zhou, Zhi-Jian Zou, Hong-Feng Guo, Jian-Yong Li & Chun Qiao. (2016) Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations. Chinese Medical Journal 129:15, pages 1778-1783.
Crossref
Catherine Strassel, Lucia Kubovcakova, Pierre H. Mangin, Catherine Ravanat, Monique Freund, Radek C. Skoda, Cécile V. Denis, Arnaud Dupuis, Raoul Herbrecht, Christian Gachet & François Lanza. (2017) Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis. Thrombosis and Haemostasis 113:02, pages 414-425.
Crossref
Jun Xia, Mi-ze Lu, Yuan-qiang Jiang, Guo-hua Yang, Yun Zhuang, Hong-li Sun & Yun-feng Shen. (2012) JAK2 V617F, MPL W515L and JAK2 exon 12 mutations in Chinese patients with primary myelofibrosis. Chinese Journal of Cancer Research 24:1, pages 72-76.
Crossref
Ana C. Glembotsky, Laura Korin, Paola R. Lev, Carlos D. Chazarreta, Rosana F. Marta, Felisa C. Molinas & Paula G. Heller. (2010) Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPL W515L‐positive platelets . European Journal of Haematology 84:5, pages 398-405.
Crossref
Guo‐Rui Ruan, Bin Jiang, Ling‐Di Li, Ji‐Hong Niu, Jin‐Lan Li, Min Xie, Ya‐Zhen Qin, Yan‐Rong Liu, Xiao‐Jun Huang & Shan‐Shan Chen. (2009) MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation‐negative chronic myeloproliferative disorders detected by a newly developed RQ‐PCR based on TaqMan MGB probes . Hematological Oncology 28:1, pages 33-39.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.